167 related articles for article (PubMed ID: 32706857)
21. The Incidence and Effect of Cytomegalovirus Disease on Mortality in Transplant Recipients and General Population: Real-world Nationwide Cohort Data.
Han SH; Yoo SG; Do Han K; La Y; Kwon DE; Lee KH
Int J Med Sci; 2021; 18(14):3333-3341. PubMed ID: 34400903
[No Abstract] [Full Text] [Related]
22. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay.
Pang X; Humar A; Preiksaitis JK
J Clin Microbiol; 2008 Dec; 46(12):4004-10. PubMed ID: 18971365
[TBL] [Abstract][Full Text] [Related]
23. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
Chou SW; Norman DJ
Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
[TBL] [Abstract][Full Text] [Related]
24. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM;
Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282
[TBL] [Abstract][Full Text] [Related]
25. Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.
Hakimi Z; Aballéa S; Ferchichi S; Scharn M; Odeyemi IA; Toumi M; Saliba F
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28599091
[TBL] [Abstract][Full Text] [Related]
26. Impact and outcomes of primary cytomegalovirus disease in seronegative abdominal solid organ transplant recipients of cytomegalovirus unexposed donors (D-/R-).
Jorgenson MR; Descourouez JL; Yang DY; Stalter LN; Leverson GE; Parajuli S; Mandelbrot DA; Smith JA; Redfield RR
Transpl Infect Dis; 2021 Jun; 23(3):e13564. PubMed ID: 33449413
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
29. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
30. Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients.
Forlanini F; Dara J; Dvorak CC; Cowan MJ; Puck JM; Dorsey MJ
Transpl Infect Dis; 2021 Apr; 23(2):e13504. PubMed ID: 33169931
[TBL] [Abstract][Full Text] [Related]
31. Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients.
Shapira G; Volkov H; Fabian I; Mohr DW; Bettinotti M; Shomron N; Avery RK; Arav-Boger R
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005904
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
[TBL] [Abstract][Full Text] [Related]
33. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
[TBL] [Abstract][Full Text] [Related]
34. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
[TBL] [Abstract][Full Text] [Related]
35. Acyclovir versus valganciclovir for preventing cytomegalovirus infection in intermediate-risk liver transplant recipients.
McKeen JT; Tsapepas DS; Li H; Anamisis A; Martin ST
Prog Transplant; 2015 Mar; 25(1):39-44. PubMed ID: 25758799
[TBL] [Abstract][Full Text] [Related]
36. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
[TBL] [Abstract][Full Text] [Related]
37. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
[TBL] [Abstract][Full Text] [Related]
38. Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.
Cervera C; Pineda M; Linares L; Marcos MA; Esteva C; Antón A; Cofán F; Ricart MJ; Navasa M; Pérez-Villa F; Pumarola T; Moreno A
Transplant Proc; 2007 Sep; 39(7):2228-30. PubMed ID: 17889146
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
[TBL] [Abstract][Full Text] [Related]
40. Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
Hofmann E; Sidler D; Dahdal S; Bittel P; Suter-Riniker F; Manuel O; Walti LN; Hirzel C
Transpl Infect Dis; 2021 Jun; 23(3):e13515. PubMed ID: 33210830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]